MacroGenics
MGNX
149 hedge funds and large institutions have $1.54B invested in MacroGenics in 2021 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 55 increasing their positions, 49 reducing their positions, and 42 closing their positions.
37% more call options, than puts
Call options by funds: $12.4M | Put options by funds: $9.05M
12% more repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 49
5.54% less ownership
Funds ownership: 100.85% → 95.31% (-5.5%)
14% less funds holding
Funds holding: 174 → 149 (-25)
15% less capital invested
Capital invested by funds: $1.8B → $1.54B (-$263M)
43% less funds holding in top 10
Funds holding in top 10: 7 → 4 (-3)
60% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 42
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Holocene Advisors
New York
|
+$43.9M |
| 2 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$39.5M |
| 3 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$29.6M |
| 4 |
State Street
Boston,
Massachusetts
|
+$16.5M |
| 5 |
RI
RTW Investments
New York
|
+$15.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Consonance Capital Management
New York
|
-$78.7M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$44.9M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
-$11.8M |
| 4 |
Goldman Sachs
New York
|
-$9.63M |
| 5 |
DGM
Darwin Global Management
St. Helier,
Jersey
|
-$9.12M |
MGNX Hedge Fund Activity: Q2 2021 in Review
149 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in MacroGenics (MGNX) for Q2 2021, worth a combined $1.54B — down 15% from $1.8B a quarter earlier.
Sellers outnumbered buyers: 42 funds closed out of MGNX and 17 opened new positions — a net loss of 25 holders — while 49 trimmed existing stakes and 55 added.
The largest buyer was Holocene Advisors, opening a new position worth an estimated $43.9M. The largest seller was Consonance Capital Management, exiting entirely with an estimated $78.7M sold.
- 149 institutional investors held MacroGenics (MGNX) as of Q2 2021, down from 174 in Q1 2021.
- Funds reported $1.54B of MacroGenics stock for Q2 2021, down 15% quarter-over-quarter.
- 17 funds opened new MacroGenics positions in Q2 2021 and 42 closed out, a net change of -25 holders.
- The largest MacroGenics buyer in Q2 2021 was Holocene Advisors, an estimated $43.9M added.
- The largest MacroGenics seller in Q2 2021 was Consonance Capital Management, an estimated $78.7M sold.
Based on aggregated 13F filings for Q2 2021.